Get started
Author

Adeline Palisse

Observed names: Palisse, Adeline, Palisse, Adeline 1985-
Institution: Galapagos (Belgium)
ORCID: 0000-0001-8944-9565
Observed ORCID: 0000-0001-8944-9565
OpenAlex ID: A5029877832
Metal-free reactions of alkynes via electrophilic iodocarbocyclizations
2012 · Adeline Palisse, Stefan F. Kirsch · Organic & Biomolecular Chemistry · 73
Domino Reactions Consisting of Heterocyclization and 1,2‐Migration—Redox‐Neutral and Oxidative Transition‐Metal Catalysis
2011 · Klaus‐Daniel Umland, Adeline Palisse, et al. · Angewandte Chemie International Edition · 44
Discovery of the S1P2 Antagonist GLPG2938 (1-[2-Ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a Preclinical Candidate for the Treatment of Idiopathic Pulmonary Fibrosis
2021 · Oscar Mammoliti, Adeline Palisse, et al. · Journal of Medicinal Chemistry · 34
Discovery and Optimization of Orally Bioavailable Phthalazone and Cinnolone Carboxylic Acid Derivatives as S1P2 Antagonists against Fibrotic Diseases
2021 · Oscar Mammoliti, Koen Jansen, et al. · Journal of Medicinal Chemistry · 22
Synthesis of Furans through Silver‐Catalyzed Propargyl–Claisen Rearrangement Followed by Cyclocondensation
2014 · Adeline Palisse, Stefan F. Kirsch · European Journal of Organic Chemistry · 20
Dominoreaktionen bestehend aus Heterocyclisierung und 1,2‐Verschiebung – redoxneutrale und oxidative Übergangsmetallkatalyse im Vergleich
2011 · Klaus‐Daniel Umland, Adeline Palisse, et al. · Angewandte Chemie · 15
Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector
2024 · Mathieu Pizzonero, Rhalid Akkari, et al. · Journal of Medicinal Chemistry · 13
Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors
2024 · Simon C. C. Lucas, J. Henry Blackwell, et al. · Journal of Medicinal Chemistry · 10
Design of a potent and selective dual JAK1/TYK2 inhibitor
2024 · Oscar Mammoliti, Christel Menet, et al. · Bioorganic & Medicinal Chemistry · 5
Structure-Based Discovery of a Series of Covalent, Orally Bioavailable, and Selective BFL1 Inhibitors
2024 · Adeline Palisse, Tony Cheung, et al. · Journal of Medicinal Chemistry · 4
HBsAg Suppression by a New Series of HBV RNA Destabilizers: Discovery and Effects on In Vitro Neurite Outgrowth
2026 · Jacques Huck, Caroline Joannesse, et al. · Journal of Medicinal Chemistry · 3
Discovery and Characterization of GLPG3808, a PAPD5/7 Inhibitor for Suppression of Hepatitis B Viral Infections
2026 · Oscar Mammoliti, Adeline Palisse, et al. · Journal of Medicinal Chemistry · 2
Identification of novel, potent, and selective JAK2V617F inhibitors
2025 · Fazal Hadi, Peter Linders, et al. · Blood · 1
PDF
Optimization and Chemoproteomic Profiling of a Selective, Covalent Bfl-1-Targeting Cellular Tool
2025 · J. Henry Blackwell, Simon C. C. Lucas, et al. · Journal of Medicinal Chemistry
CCDC 2122384: Experimental Crystal Structure Determination
2021 · Mammoliti, Oscar, Jansen, Koen, et al. · The Cambridge Structural Database
CCDC 2122349: Experimental Crystal Structure Determination
2021 · Mammoliti, Oscar, Jansen, Koen, et al. · The Cambridge Structural Database
Cascade Reactions Initiated by ᴨ - Activation. A Flexible Way to Heterocycles & Studies toward the Total Synthesis of Melohenine B
2018 · Adeline Palisse
ChemInform Abstract: Synthesis of Furans Through Silver‐Catalyzed Propargyl‐Claisen Rearrangement Followed by Cyclocondensation.
2015 · Adeline Palisse, Stefan F. Kirsch · ChemInform
ChemInform Abstract: Metal‐Free Reactions of Alkynes via Electrophilic Iodocarbocyclizations
2013 · Adeline Palisse, Stefan F. Kirsch · ChemInform
ChemInform Abstract: Domino Reactions Consisting of Heterocyclization and 1,2‐Migration—Redox‐Neutral and Oxidative Transition‐Metal Catalysis.
2012 · Klaus‐Daniel Umland, Adeline Palisse, et al. · ChemInform
Works count: 21
Citation count: 246
H-index: 8
I10-index: 8
Year
Topic
Type